AKT1 and diffuse large B-cell lymphoma: COO DLBCL subtypes exhibit dependence on phosphatidylinositol-3-kinase (PI3K)/protein kinase-B (AKT) leading to mammalian target of rapamycin complex-1 (mTORC1) activity [5].